Another large sequencing study reported a lower incidence of KDM6A driver mutations in AML (10 of 1540 cases), whereas a more recent study used a different gene panel and reported an incidence of 27% (32 of 119 cases) [19, 20]. This evidence concerns the gene KDM6A and acute myeloid leukemia.